Cancer Medicine

Papers
(The H4-Index of Cancer Medicine is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Molecular profiling of colorectal cancer in a genetically admixed Hispanic population309
SIRT2 inhibitor SirReal2 enhances anti‐tumor effects of PI3K/mTOR inhibitor VS‐5584 on acute myeloid leukemia cells166
Evaluating implementation of a hospital‐based cancer registry to improve childhood cancer care in low‐ and middle‐income countries108
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M‐positive non‐small cell lung cancer102
Outcome and Challenges in the Treatment of Pediatric Hodgkin Lymphoma With Euronet‐PHL‐C1 Protocol: Experience From a Resource‐Limited Country101
Clinical Features and T‐Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC‐TFR Study87
Social Determinants of Health Predict Sleep–Wake Disturbances Among Patients Living With Primary Brain Tumors: A Cross‐Sectional Analysis86
The Association Between Psychological Distress, Emergency Room Visits, and All‐Cause Mortality Among Colorectal Cancer Survivors85
Inflammatory geriatric nutritional risk index stratified the survival of older adults with cancer sarcopenia84
Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer80
Predicting Neoplastic Polyp in Patients With Gallbladder Polyps Using Interpretable Machine Learning Models: Retrospective Cohort Study76
Racial and ethnic disparities in mortality among World Trade Center Health Registry enrollees with post‐9/11 cancer71
Issue Information71
Cardiovascular Medication and Health Service Use in Individuals With Cancer: A Retrospective Population‐Based Cohort Study69
Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis68
Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population68
Issue Information62
Cancer and the family: Variations by sex and race/ethnicity56
Effects of FABP5 Expression on Clinicopathological and Survival Characteristics in Digestive System Malignancies: A Systematic Review and Meta‐Analysis55
Risk Factors for Financial Toxicity in Patients With Pancreatic Cancer55
Impact of Body Image Perception on Behavioral Outcomes in Chinese Adolescent and Young Adult Survivors of Sarcoma55
Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population55
Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation54
Issue Information54
Physical Activity Patterns According to Demographic, Social, and Clinical Correlates Among Breast Cancer Survivors53
Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma52
Oil blotting paper for formalin fixation increases endoscopic ultrasound‐guided tissue acquisition‐collected sample volumes on glass slides52
Intake of polyphenols from cereal foods and colorectal cancer risk in the Melbourne Collaborative Cohort Study51
Initial Feasibility and Acceptability of Cancer Pain 101: An Interdisciplinary, Single‐Session, Telehealth Intervention for Patients With Cancer‐Related Pain50
50
Improved risk scoring systems for colorectal cancer screening in Shanghai, China48
Body mass index and incident cardiometabolic conditions in relation to obesity‐related cancer risk: A population‐based cohort study in Catalonia, Spain46
Examining the involvement of guardians of children with acute lymphoblastic leukemia in Tanzania as public contributors to inform the design and conduct of the GuardiansCan project: A mixed46
Machine learning‐based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results45
Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II44
Traditional Chinese medicines and capecitabine‐based chemotherapy for colorectal cancer treatment: A meta‐analysis44
Impact of race/ethnicity and language preferences on pediatric ALL survival outcomes44
Immune‐check blocking combination multiple cytokines shown curative potential in mice tumor model44
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion43
Risk factors for early mortality of lung cancer patients in France: A nationwide analysis43
Front‐line treatment efficacy and clinical outcomes of elderly patients with multiple myeloma in a real‐world setting: A multicenter retrospective study in China42
Exploration of the breast ductal carcinoma in situ signature and its prognostic implications42
0.19933700561523